Johnson & Johnson pauses COVID-19 vaccine trial over patient exhibiting an 'unexplained illness'
The company released a statement on Monday, saying "We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 Ensemble trial, due to an unexplained illness in a study participant." The study aimed to test 60,000 participants across the US, Argentina, Brazil and several other countries. In September, pharmaceutical company AstraZeneca paused clinical trials of an experimental COVID-19 vaccine after a participant in the UK had an unexplained illness, but the study has since resumed in the country.
